Hot Products

CAL-29

Cat.No.: CSC-C0524

Species: Human

Source: urinary bladder transitional cell carcinoma

Morphology: adherent epitheloid cells growing as monolayers

Culture Properties: monolayer

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C0524
Description
Established from the primary lesion of a fatally invasive, metastatic transitional cell carcinoma of the bladder (grade IV, stage T2) from an 80-year-old woman before treatment
Species
Human
Source
urinary bladder transitional cell carcinoma
Recommended Medium
90% DMEM + 10% h.i.FBS
Culture Properties
monolayer
Morphology
adherent epitheloid cells growing as monolayers
Karyotype
Human flat-moded hypertriploid karyotype with 8% polyploidy - 71(63-74)<3n>XX/XXX, -4, +9, -11, -13, -17, +20, +3mar, +1-6 dmin, i(3q), add(7)(q22)x1-2, del(7)(q32)x2, del(9)(p21), del(10)(p13), add(12)(p1?3), add(19)(p13)
Quality Control
Mycoplasma: negative in microbiological culture, PCR assays
Immunology: cytokeratin +, cytokeratin-7 -, cytokeratin-8 +, cytokeratin-17 +, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin -
Viruses: PCR:
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 1 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

CAL-29 is a cell line of urothelial carcinoma of the bladder, isolated from an 80-year-old female patient with muscle-invasive bladder cancer (T2 stage, MIBC). The MIBC subtype of bladder cancer is the most common form of this cancer, which is also very heterogeneous and aggressive. Under laboratory conditions, CAL-29 cells exhibit normal epithelial cell structure. Researchers use this cell line as a platform for testing and confirming the effectiveness of potential anti-cancer medications. For instance, hemocyanin and its functional units (FUs) from mollusks have demonstrated significant anti-tumor activity against CAL-29 cells, with better efficacy than that of the conventional chemotherapeutic drug doxorubicin. Dihydroanthraquinone compounds extracted from stem bark of Kigelia africana also showed cytotoxicity against CAL-29 cells. CAL-29 cells are also used to study molecular mechanisms of bladder cancer. A study reported the interaction between the WWOX gene and the AP-2α and AP-2γ transcription factors, and the regulatory role of the LINC01137/miR-186-5p/WWOX axis in bladder cancer, by using the stable lentiviral transduction of CAL-29 cells and the high-throughput sequencing technology. The cell line is also applied in basic biological studies, such as cell metabolism and signaling pathways. For example, the metabolomics analysis has been used to profile the metabolic response of CAL-29 cells with different drug treatment.

Cell Line-Based Human Bladder Organoids with Bladder-like Self-Organization—A New Standardized Approach in Bladder Cancer Research

Bladder cancer therapy development is limited by the lack of robust in vitro models that replicate tumor complexity. While patient-derived organoids show promise, they suffer from low establishment rates and inconsistent reproducibility.

Berndt-Paetz et al. employed a standardized approach using ultra-low attachment plates to generate organoids from four human BCa cell lines (RT-4, RT-112, T-24 and CAL-29), co-cultured with bladder fibroblasts and smooth muscle cells. After only 24 h, uniform spheroids form spontaneously and were able to further develop over 7 days (Fig. 1a). RT-112 organoids on day 4, 5 and 7 are shown as an example. The formation from day 1 to 4 is shown in Figure 2. Organoids were then fixed, processed and evaluated by HE staining. After 4 days, all cultures already have distinct structures, defined by a peripheral layer and inner organoid core. In RT-4, RT-112, and CAL-29, the outer layer forms a compact border. In contrast, the outer cells of the T-24 organoids are more loosely arranged (Fig. 1b). Organoids reached a size between 650 and 1000 µm in diameter after 96 h, without any sign of central necrosis. Overall, organoid size decreased with increasing tumor grade (Fig. 1c and d). The only exception was RT-4, which did not develop a clearly defined structure. In all cell lines except RT-4, the spheroids completely lost their structural integrity by day 7 (Fig. 2). Thus, the authors selected 4-day-old organoids for the following analysis.

Spontaneous Formation of Heterogeneous, Compact Bladder Cancer (BCa) Organoids. Bladder cancer cells (RT-4, RT-112, T-24, CAL-29) were co-cultured with human bladder fibroblasts (hBF) and human bladder smooth muscle cells (hBSMC) in an ultra-low attachment (ULA) plate.Fig. 1. Spontaneous formation of heterogeneous, compact BCa organoids. BCa cells (RT-4, RT-112, T-24, CAL-29) were co-cultured with hBF and hBSMC in an ULA plate (Berndt-Paetz M, Han S, et al., 2023).

Live Cell Observation and Histology of Bladder Cancer (BCa) Organoids.Fig. 2. Live cell observation and histology of BCa organoids (Berndt-Paetz M, Han S, et al., 2023).

Production of Saponins from In Vitro Cultures of Astragalus Glycyphyllos and Their Antineoplastic Activity

Natural production of saponins from Astragalus glycyphyllos is not sufficient and its environment-friendly collecting is not sustainable. In vitro plant cultures may serve as a platform for regular and relatively high-yield production of secondary bioactive compounds. In the current study, callus, shoot and suspension cultures of A. glycyphyllos were established using different media and culture conditions optimized to these types of cultures. Content of saponins was determined using LC-MS and cytotoxicity of saponin-rich fractions obtained from the shoot culture were assessed towards a range of human cancer cell lines.

Antineoplastic activity of saponin-containing fractions 1–3 (wild-grown) and 4–6 (in vitro cultures) was determined towards various human tumor cell lines using MTT assay (Fig. 3). In all cases tumor growth was dose-dependently inhibited. The fractions 4–6 showed a more prominent cytotoxic activity against all cell lines tested based on the IC50 values. This fraction was particularly effective against lymphoma cell lines MJ and HUT-78 (IC50: 74.5 and 77.8 µg/mL). Fraction 1–3 was more variable and cells of T-24 bladder carcinoma were the least sensitive (IC50: 168.4 µg/mL), and HUT-78 the most sensitive (IC50: 87.6 µg/mL). However, the CAL-29 bladder cells, also expressing MDR1 (gp170), were more sensitive than T-24 cells, and MDR1 level in CAL-29 is significantly higher.

Viability of T-24, CAL-29, MJ, and HUT-78 Cells After 72-Hour Exposure to Various Concentrations of Fractions 1-3 and 4-6.Fig. 3. Viability of T-24, CAL-29, MJ and HUT-78 cells following 72 h exposure to various concentrations of fractions 1-3 and 4-6 (Shkondrov A, Krasteva I, et al., 2019).

What is the recommended incubation conditions for the product?

We recommend 95% air, 5% CO2, 37°C and 70%-80% humidity in the incubator.

Ask a Question

Average Rating: 5.0    |    1 Scientist has reviewed this product

Good performance

Our group has purchased a number of cellular products from here, all of which have performed well.

03 Apr 2021


Ease of use

After sales services

Value for money


Write your own review

  • You May Also Need
CM-1010X

For research use only. Not for any other purpose.